雌激素受体基因、认知下降与阿尔茨海默病
研究在两项纵向临床病理老化研究中随访平均10年,评估女性(N=1711)和男性(N=651)的雌激素受体基因变异与阿尔茨海默病认知及病理特征的关联。女性中GPER1 DNA甲基化与认知下降、tau缠结密度和整体AD病理评分相关,GPER1 RNA表达与认知下降和tau缠结密度相关;男性中关联较弱。
要点
- 女性中GPER1 DNA甲基化与认知下降、tau缠结密度及整体AD病理评分相关。
- 女性DLPFC中GPER1 RNA表达与认知下降和tau缠结密度相关。
- 男性中ER分子基因组变异与AD认知和病理特征的关联较弱。
核心结论
- 女性中ER DNA甲基化和RNA表达、以及一定程度上的ER多态性与AD认知和病理特征相关,男性中关联较弱。
研究设计与样本
- 参与者来自两项纵向临床病理老化研究之一,随访平均10年。
- 女性N=1711,基线平均年龄78.0岁(SD=7.7);男性N=651,基线平均年龄77.4岁(SD=7.3)。
- 整体认知采用源自19项神经心理学测试评分的复合评分评估。
- 尸检病理评估包括3项AD病理(免疫组化检测淀粉样β和tau缠结,以及由弥漫性和神经炎性斑块及神经原纤维缠结计数得出的整体AD病理评分)和8项非AD病理指标。
- ER分子基因组变异包括基因分型以及检测脑区(包括DLPFC)的ER DNA甲基化和RNA表达。
主要发现
- 女性中GPER1分子变异与AD特征的关联最一致。
- 女性中GPER1 DNA甲基化与认知下降、tau缠结密度和整体AD病理评分相关。
- 女性DLPFC中GPER1 RNA表达与认知下降和tau缠结密度相关。
- 女性中ER2和ER1序列变异及DNA甲基化与认知相关;DLPFC中参与激活ER信号机制基因的RNA表达也与认知下降和tau缠结密度相关。
- 男性中ER分子基因组变异与AD认知和病理特征的关联较弱;两性中均未见到ER分子基因组变异与非AD病理的一致关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Lifetime risk of Alzheimer disease (AD) dementia is twofold higher in women compared with men, and low estrogen levels in postmenopause have been suggested as a possible contributor. We examined 3 ER (GPER1, ER2, and ER1) variants in association with AD traits as an indirect method to test the association between estrogen and AD in women. Although the study focus was on women, in a comparison, we separately examined ER molecular variants in men. METHODS: Participants were followed for an average of 10 years in one of the 2 longitudinal clinical pathologic studies of aging. Global cognition was assessed using a composite score derived from 19 neuropsychological tests' scores. Postmortem pathologic assessment included examination of 3 AD (amyloid-β and tau tangles determined by immunohistochemistry, and a global AD pathology score derived from diffuse and neurotic plaques and neurofibrillary tangle count) and 8 non-AD pathology indices. ER molecular genomic variants included genotyping and examining ER DNA methylation and RNA expression in brain regions including the dorsolateral prefrontal cortex (DLPFC) that are major players in cognition and often have AD pathology. RESULTS: The mean age of women (N = 1711) at baseline was 78.0 (SD = 7.7) years. In women, GPER1 molecular variants had the most consistent associations with AD traits. GPER1 DNA methylation was associated with cognitive decline, tau tangle density, and global AD pathology score. GPER1 RNA expression in DLPFC was related to cognitive decline and tau tangle density. Other associations included associations of ER2 and ER1 sequence variants and DNA methylation with cognition. RNA expressions in DLPFC of genes involved in signaling mechanisms of activated ERs were also associated with cognitive decline and tau tangle density in women. In men (N = 651, average age at baseline: 77.4 [SD = 7.3]), there were less robust associations between ER molecular genomic variants and AD cognitive and pathologic traits. No consistent association was seen between ER molecular genomic variations and non-AD pathologies in either of the sexes. DISCUSSION: ER DNA methylation and RNA expression, and to some extent ER polymorphisms, were associated with AD cognitive and pathologic traits in women, and to a lesser extent in men.
引用
- Oveisgharan S, Yang J, Yu L, et al. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023. PMID: 36697247. doi:10.1212/WNL.0000000000206833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。